Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD

[1]  M. Gurney,et al.  A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis , 1997, Acta Neuropathologica.

[2]  D. Borchelt,et al.  ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.

[3]  A Hirano,et al.  Neuropathology of ALS , 1996, Neurology.

[4]  K. Nakashima,et al.  Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. , 1996, Journal of neuropathology and experimental neurology.

[5]  A. Taniguchi,et al.  Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND , 1996, Journal of the Neurological Sciences.

[6]  M. Gurney,et al.  PRESENCE OF SUPEROXIDE DISMUTASE-1 (SOD1) IMMUNOREACTIVITY IN HYALINE INCLUSION BODIES OF THE SPINAL CORD NEURONS OF TRANSGENIC MICE FOR MUTANT SOD1 GENE , 1996 .

[7]  W. Hung,et al.  Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.

[8]  M. Gurney,et al.  Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[9]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[10]  J. Tainer,et al.  Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Borchelt,et al.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.

[12]  H. Takahashi.  [Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene]. , 1995, No to shinkei = Brain and nerve.

[13]  K. Asada,et al.  Attachment of CuZn-Superoxide Dismutase to Thylakoid Membranes at the Site of Superoxide Generation (PSI) in Spinach Chloroplasts: Detection by Immuno-Gold Labeling After Rapid Freezing and Substitution Method , 1995 .

[14]  P. Andersen,et al.  Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase , 1995, Nature Genetics.

[15]  M. Gurney,et al.  Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) , 1995, Brain Research.

[16]  D. Borchelt,et al.  Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Rowland.  Amyotrophic lateral sclerosis: human challenge for neuroscience. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Borchelt,et al.  Superoxide Dismutase 1 Subunits with Mutations Linked to Familial Amyotrophic Lateral Sclerosis Do Not Affect Wild-type Subunit Function (*) , 1995, The Journal of Biological Chemistry.

[19]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Desideri,et al.  Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis , 1994, FEBS letters.

[21]  M. Gurney,et al.  Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. , 1994, The American journal of pathology.

[22]  D. Price,et al.  Motor neurone disease and animal models , 1994, Neurobiology of Disease.

[23]  J. Valentine,et al.  Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Borchelt,et al.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Gurney,et al.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.

[26]  J. Rothstein,et al.  Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Bucala,et al.  Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[28]  M. Pericak-Vance,et al.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.

[29]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[30]  K. Ohkawa,et al.  Inhibitory effect of nonenzymatic glycation on ubiquitination and ubiquitin-mediated degradation of lysozyme. , 1993, Biochemical and biophysical research communications.

[31]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[32]  N. Taniguchi,et al.  Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. , 1992, The Journal of biological chemistry.

[33]  J. Tainer,et al.  Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Ho,et al.  Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. , 1990, Genomics.

[35]  R. Nussbaum,et al.  Report of the committee on the genetic constitution of the X chromosome. , 1988, Cytogenetics and cell genetics.

[36]  S. Fujii,et al.  Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. , 1987, The Journal of biological chemistry.

[37]  J. Crapo,et al.  Intracellular localization of the copper-zinc and manganese superoxide dismutases in rat liver parenchymal cells. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[38]  K. Asayama,et al.  Selective induction of manganous superoxide dismutase in human monocytes. , 1985, The American journal of physiology.

[39]  O. Stein,et al.  Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. , 1985, The EMBO journal.

[40]  L. Kurland,et al.  Fine Structural Study of Neurofibrillary Changes in a Family with Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.

[41]  L. Sternberger,et al.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Holme,et al.  Superoxide dismutase in extracellular fluids. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[43]  I. Fridovich,et al.  Superoxide dismutase. Organelle specificity. , 1973, The Journal of biological chemistry.

[44]  H. F. Deutsch,et al.  Subunit structure of human superoxide dismutase. , 1972, The Journal of biological chemistry.

[45]  I. Fridovich,et al.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). , 1969, The Journal of biological chemistry.

[46]  L. Kurland,et al.  Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. , 1967, Archives of neurology.

[47]  N. Shibata,et al.  Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. , 1996, Developmental neuroscience.

[48]  J. Chen,et al.  Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. , 1994, Progress in brain research.

[49]  O. Elroy-Stein,et al.  Cell damage by excess CuZnSOD and Down's syndrome. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  T. Umahara,et al.  IMMUNOHISTOCHEMICAL DEMONSTRATION OF Cu/Zn SUPEROXIDE DISMUTASE IN THE SPINAL CORD OF PATIENTS WITH FAMILIAL AMYOTRO-PHIC LATERAL SCLEROSIS , 1993 .

[51]  V. Monnier.  Toward a Maillard reaction theory of aging. , 1989, Progress in clinical and biological research.

[52]  M. Rechsteiner,et al.  Ubiquitin-mediated pathways for intracellular proteolysis. , 1987, Annual review of cell biology.